Healthcare provider profile · identity verified

Ted Albert Bauman, MD

Family Practice · CLINTON, NC · NPI 1205860970

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	514	116
Pantoprazole Sodium	Pantoprazole Sodium	377	92
Amlodipine Besylate	Amlodipine Besylate	354	92
Rosuvastatin Calcium	Rosuvastatin Calcium	351	93
Prednisone	Prednisone	255	168
Metformin Hcl Er	Metformin Hcl	243	52
Meloxicam	Meloxicam	237	72
Trazodone Hcl	Trazodone Hcl	200	48
Levothyroxine Sodium	Levothyroxine Sodium	193	43
Losartan Potassium	Losartan Potassium	190	50
Metoprolol Succinate	Metoprolol Succinate	181	53
Omeprazole	Omeprazole	178	49
Valsartan	Valsartan	174	47
Azithromycin	Azithromycin	171	147
Jardiance	Empagliflozin	163	22
Celecoxib	Celecoxib	161	50
Fluticasone Propionate	Fluticasone Propionate	152	51
Lisinopril	Lisinopril	144	32
Metoprolol Tartrate	Metoprolol Tartrate	130	27
Tamsulosin Hcl	Tamsulosin Hcl	129	32
Tramadol Hcl	Tramadol Hcl	129	29
Duloxetine Hcl	Duloxetine Hcl	128	26
Gabapentin	Gabapentin	126	31
Pioglitazone Hcl	Pioglitazone Hcl	122	27
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	114	27
Potassium Chloride	Potassium Chloride	112	31
Glimepiride	Glimepiride	104	24
Hydrochlorothiazide	Hydrochlorothiazide	101	28
Carvedilol	Carvedilol	96	26
Albuterol Sulfate Hfa	Albuterol Sulfate	88	39
Diclofenac Sodium	Diclofenac Sodium	87	45
Allopurinol	Allopurinol	86	21
Bupropion Xl	Bupropion Hcl	80	19
Cefdinir	Cefdinir	80	72
Famotidine	Famotidine	80	28
Baclofen	Baclofen	74	38
Pravastatin Sodium	Pravastatin Sodium	72	16
Enalapril Maleate	Enalapril Maleate	71	15
Alprazolam	Alprazolam	70	19
Doxycycline Monohydrate	Doxycycline Monohydrate	70	45
Januvia	Sitagliptin Phosphate	70	suppressed
Montelukast Sodium	Montelukast Sodium	70	21
Nortriptyline Hcl	Nortriptyline Hcl	70	19
Fluoxetine Hcl	Fluoxetine Hcl	68	15
Cefuroxime	Cefuroxime Axetil	66	46
Clopidogrel	Clopidogrel Bisulfate	64	18
Tizanidine Hcl	Tizanidine Hcl	63	29
Metformin Hcl	Metformin Hcl	62	14
Methylprednisolone	Methylprednisolone	61	48
Citalopram Hbr	Citalopram Hydrobromide	58	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	57	51
Eliquis	Apixaban	55	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	54	13
Simvastatin	Simvastatin	54	14
Zolpidem Tartrate	Zolpidem Tartrate	54	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	14
Telmisartan	Telmisartan	53	13
Buspirone Hcl	Buspirone Hcl	48	17
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	48	21
Escitalopram Oxalate	Escitalopram Oxalate	47	13
Furosemide	Furosemide	46	17
Janumet Xr	Sitagliptin Phos/Metformin Hcl	46	suppressed
Chlorthalidone	Chlorthalidone	44	12
Amitriptyline Hcl	Amitriptyline Hcl	43	suppressed
Ezetimibe	Ezetimibe	43	suppressed
Breo Ellipta	Fluticasone/Vilanterol	40	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	suppressed
Myrbetriq	Mirabegron	39	suppressed
Sertraline Hcl	Sertraline Hcl	38	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	36	suppressed
Atenolol	Atenolol	36	suppressed
Fenofibrate	Fenofibrate	35	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	33	suppressed
Finasteride	Finasteride	30	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	30	suppressed
Ketoconazole	Ketoconazole	30	15
Xarelto	Rivaroxaban	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Clonazepam	Clonazepam	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Fluconazole	Fluconazole	24	22
Glipizide Er	Glipizide	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Verapamil Er	Verapamil Hcl	23	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Mupirocin	Mupirocin	22	18
Ozempic	Semaglutide	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Meclizine Hcl	Meclizine Hcl	20	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Hydrocortisone	Hydrocortisone	19	12
Lorazepam	Lorazepam	19	suppressed
Rybelsus	Semaglutide	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Cefadroxil	Cefadroxil	18	17
Estradiol	Estradiol	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	14
Benazepril Hcl	Benazepril Hcl	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Topiramate	Topiramate	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Diazepam	Diazepam	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	14
Warfarin Sodium	Warfarin Sodium	16	suppressed
Methimazole	Methimazole	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Clindamycin Hcl	Clindamycin Hcl	14	12
Indapamide	Indapamide	14	suppressed
Invokana	Canagliflozin	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Diclofenac Sodium-Misoprostol	Diclofenac Sodium/Misoprostol	11	suppressed
Glyburide	Glyburide	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error